おすすめの製品
詳細
Enterococcus faecalis is a gram positive, non-motile, facultative anaerobic, coci-shaped bacterium.1,2 It is a commensal bacterium of the human gut and a major opportunistic pathogen in susceptible hosts.1 E. faecalis is the third most common pathogen associated with hospital-acquired infections.2 E. faecalis inhabits the gut in 80% of healthy adultsand is also a part of the oral cavity normal flora in 20% of the adult population. In addition, E. faecalis was also identified in the human urinary tract.1
特異性
Anti-Enterococcus faecalis antibody recognizes E. faecalis lysate and whole dead bacteria
アプリケーション
The antibody may be used in various immunochemical techniques including Immunoblotting. Detection of the E. faecalis bands by Immunoblotting is specifically inhibited by the immunogen.
生物化学的／生理学的作用
E. faecalis contributes to the host in several ways, such as, competing with pathogen bacteria and preventing them from reaching the gut epithelia, prevention of intestinal epithelial barrier leakage and provision of protection from pathogens to the young infant through breast milk consumption.1,3-5
Moreover, E. faecalis also has many effects on the immune system that are beneficial to the host, such as, promoting the secretion of anti-inflammatory cytokines IL-10 and TGF-ß and induction of IgA production.1,6,7
However, when the homeostasis in the gut and mucus barrier is disrupted, especially in susceptible individuals such as in inflammatory bowel diseases (IBD) patients, or upon antibiotic administration, E. faecalis might become an opportunistic pathogen. In such case, the bacteria population overgrows and translocates through the mucus barrier to reach the epithelial cells of the gut where it can enter the bloodstream and the lymphatic system and cause severe inflammation.
Moreover, E. faecalis also has many effects on the immune system that are beneficial to the host, such as, promoting the secretion of anti-inflammatory cytokines IL-10 and TGF-ß and induction of IgA production.1,6,7
However, when the homeostasis in the gut and mucus barrier is disrupted, especially in susceptible individuals such as in inflammatory bowel diseases (IBD) patients, or upon antibiotic administration, E. faecalis might become an opportunistic pathogen. In such case, the bacteria population overgrows and translocates through the mucus barrier to reach the epithelial cells of the gut where it can enter the bloodstream and the lymphatic system and cause severe inflammation.
物理的形状
Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.
保管および安定性
For continuous use, store at 2-8°C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.
免責事項
Unless otherwise stated in our catalog our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
保管分類コード
12 - Non Combustible Liquids
WGK
nwg
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
SAB4200868-BULK:
SAB4200868-100UL:
SAB4200868-25UL:
SAB4200868-VAR:
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）